| Dr David Cunningham, MD | |
|
1 Corporate Pl, Middletown, RI 02842-6406 | |
| (401) 619-4884 | |
| (401) 619-4886 |
| Full Name | Dr David Cunningham |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 37 Years |
| Location | 1 Corporate Pl, Middletown, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720073406 | NPI | - | NPPES |
| 709004149 | Other | RI | GROUP MEDICARE |
| 1992239081 | Other | RI | NPI TYPE 2 |
| 7000545 | Medicaid | RI | |
| P00249981 | Other | RI | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD07724 (Rhode Island) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Visiting Nurse Home And Hospice | Portsmouth, RI | Home health agency |
| Beacon Hospice, An Amedisys Company | East providence, RI | Hospice |
| Newport Hospital | Newport, RI | Hospital |
| The Miriam Hospital | Providence, RI | Hospital |
| Southcoast Hospitals Group | Fall river, MA | Hospital |
| Rhode Island Hospital | Providence, RI | Hospital |
| Entity Name | University Concierge Medicine Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992239081 PECOS PAC ID: 2365719085 Enrollment ID: O20170601000876 |
News Archive
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company whose products include BioGlue Surgical Adhesive, announced today that it has completed the purchase of U.S. patent # 6,329,337. The patent involves the formulation and use of recombinant human serum albumin and gluteraldehyde, and now becomes part of CryoLife's protein hydrogel patent portfolio, which includes BioGlue.
When viruses such as influenza and Ebola jump from one species to another, their ability to cause harm can change dramatically, but research from the University of Cambridge shows that it may be possible to predict the virus's virulence by looking at how deadly it is in closely-related species.
For the first time, researchers have used a technique called optical imaging to visualize changes in nerve connections when flies learn. These changes may be the beginning of a complex chain of events that leads to formation of lasting memories.
This month, Molecular Pharmaceutics reported promising findings from the Nemours Center for Childhood Cancer Research and the Materials Science and Engineering Department at the University of Delaware, about the potential for nanotechnology to deliver chemotherapeutic agents in a way that attacks cancer cells without harming healthy cells.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Cunningham, MD 10 Davol Sq, Suite 400, Providence, RI 02903-4754 Ph: (401) 421-4000 | Dr David Cunningham, MD 1 Corporate Pl, Middletown, RI 02842-6406 Ph: (401) 619-4884 |
News Archive
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company whose products include BioGlue Surgical Adhesive, announced today that it has completed the purchase of U.S. patent # 6,329,337. The patent involves the formulation and use of recombinant human serum albumin and gluteraldehyde, and now becomes part of CryoLife's protein hydrogel patent portfolio, which includes BioGlue.
When viruses such as influenza and Ebola jump from one species to another, their ability to cause harm can change dramatically, but research from the University of Cambridge shows that it may be possible to predict the virus's virulence by looking at how deadly it is in closely-related species.
For the first time, researchers have used a technique called optical imaging to visualize changes in nerve connections when flies learn. These changes may be the beginning of a complex chain of events that leads to formation of lasting memories.
This month, Molecular Pharmaceutics reported promising findings from the Nemours Center for Childhood Cancer Research and the Materials Science and Engineering Department at the University of Delaware, about the potential for nanotechnology to deliver chemotherapeutic agents in a way that attacks cancer cells without harming healthy cells.
› Verified 3 days ago
Dr. Susan Mary Green, M. D. M.P.H. Internal Medicine Medicare: Medicare Enrolled Practice Location: 333 Valley Rd, Middletown, RI 02842 Phone: 401-619-1540 Fax: 401-619-1690 | |
Dr. Robert H Schwengel, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 676 Aquidneck Ave, Middletown, RI 02842 Phone: 401-849-9042 Fax: 401-849-7540 | |
John J Hand, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 672 Aquidneck Ave, Middletown, RI 02842 Phone: 401-847-0519 Fax: 401-846-0283 | |
Dr. Jayanthi Parameswaran, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 672 Aquidneck Ave, Middletown, RI 02842 Phone: 401-847-0519 Fax: 401-846-0283 | |
Dr. Robert Cicchelli, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 850 Aquidneck Ave, Middletown, RI 02842 Phone: 401-846-0055 Fax: 401-842-0963 | |
Dr. Norman Eric Rudolph, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 333 Valley Rd, Middletown, RI 02842 Phone: 401-849-3925 Fax: 401-849-3929 | |
Carol Marie Ryan, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1 Corporate Pl, Middletown, RI 02842 Phone: 401-273-7100 |